Leili Mohebnasab: Understanding Placental Health Through Epigenetics
Leili Mohebnasab, Midwife at Shariati Hospital, shared a post on LinkedIn:
“Epigenetic Biomarkers of Placental Health:
What DNA Methylation Reveals—and Where It Must Remain Silent
For decades, placental health has been assessed indirectly—through fetal growth patterns, Doppler findings, and late clinical syndromes such as preeclampsia or preterm birth. These approaches detect outcomes, not the biological processes unfolding earlier in pregnancy.
Epigenetics offers a different perspective.
According to guidance and research priorities from the World Health Organization, NIH-supported placental biology programs, and CDC population health frameworks (2020–2025), epigenetic markers—particularly DNA methylation (DNAm)—reflect how the placenta adapts to its environment over time.
The placenta is epigenetically dynamic
Placental tissue undergoes rapid differentiation, immune modulation, and metabolic adaptation. NIH research shows that DNAm patterns shift predictably across gestation as part of normal development. These changes are not signs of damage—they are features of placental biology.
When timing appears altered
In some complicated pregnancies, placental DNAm patterns suggest biological ‘age acceleration,’ meaning the placenta appears epigenetically older than expected for gestational age. WHO emphasizes that this reflects cumulative biological stress—not inevitable pathology or outcome.
What epigenetic biomarkers can tell us
At the population level, altered DNAm patterns have been associated with placental insufficiency, fetal growth restriction, and hypertensive disorders of pregnancy. These associations deepen biological understanding but do not provide individual prediction.
What they cannot do
Global guidance is clear:
- epigenetic markers are not screening tools,
- they do not establish causality,
- they do not justify intervention in asymptomatic pregnancy.
A clinical and midwifery perspective
Epigenetic research reframes how we understand placental adaptation—but it does not change the foundations of care. Clinical assessment, physiological monitoring, and continuity remain central.
Epigenetics records responsiveness—not destiny.
WHO | NIH | CDC (2020–2025)
Question for you
How can we use epigenetic insight to improve understanding of placental health without turning adaptive biology into deterministic labels?”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO